{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:22:45Z","timestamp":1771568565209,"version":"3.50.1"},"reference-count":111,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Batten disease or neuronal ceroid lipofuscinosis (NCL) is a group of rare, fatal, inherited neurodegenerative lysosomal storage disorders. Numerous genes (CLN1\u2013CLN8, CLN10\u2013CLN14) were identified in which mutations can lead to NCL; however, the underlying pathophysiology remains elusive. Despite this, the NCLs share some of the same features and symptoms but vary in respect to severity and onset of symptoms by age. Some common symptoms include the progressive loss of vision, mental and motor deterioration, epileptic seizures, premature death, and in the rare adult-onset, dementia. Currently, all forms of NCL are fatal, and no curative treatments are available. Induced pluripotent stem cells (iPSCs) can differentiate into any cell type of the human body. Cells reprogrammed from a patient have the advantage of acquiring disease pathogenesis along with recapitulation of disease-associated phenotypes. They serve as practical model systems to shed new light on disease mechanisms and provide a phenotypic screening platform to enable drug discovery. Herein, we provide an overview of available iPSC models for a number of different NCLs. More specifically, we highlight findings in these models that may spur target identification and drug development.<\/jats:p>","DOI":"10.3390\/molecules26206235","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T23:05:47Z","timestamp":1634511947000},"page":"6235","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Patient-Derived Induced Pluripotent Stem Cell Models for Phenotypic Screening in the Neuronal Ceroid Lipofuscinoses"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0269-8652","authenticated-orcid":false,"given":"Ahmed","family":"Morsy","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9722-5254","authenticated-orcid":false,"given":"Angelica V.","family":"Carmona","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4947-5782","authenticated-orcid":false,"given":"Paul C.","family":"Trippier","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68106, USA"},{"name":"Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68106, USA"},{"name":"UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, NE 68106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/s100720070038","article-title":"Neuronal ceroid lipofuscinoses in childhood","volume":"21","author":"Santavuori","year":"2000","journal-title":"Neurol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/brain\/awl107","article-title":"Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis","volume":"129","author":"Siintola","year":"2006","journal-title":"Brain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/0883073813494268","article-title":"Classification and natural history of the neuronal ceroid lipofuscinoses","volume":"28","author":"Mink","year":"2013","journal-title":"J. Child Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/15548627.2019.1637200","article-title":"Enzyme replacement therapy with recombinant pro-CTSD (cathepsin D) corrects defective proteolysis and autophagy in neuronal ceroid lipofuscinosis","volume":"16","author":"Marques","year":"2020","journal-title":"Autophagy"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","article-title":"Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis","volume":"38","author":"Arrant","year":"2018","journal-title":"J. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum. Mutat."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Mirza, M., Volz, C., Karlstetter, M., Langiu, M., Somogyi, A., Ruonala, M.O., Tamm, E.R., Jagle, H., and Langmann, T. (2013). Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: A beneficial effect of DHA and curcumin supplementation. PLoS ONE, 8.","DOI":"10.1371\/annotation\/ae907882-62e0-4803-8c00-35b30a649fe9"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1006\/mgme.1999.2808","article-title":"Progress in neuropathology of the neuronal ceroid lipofuscinoses","volume":"66","author":"Goebel","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/088307389601100408","article-title":"Electron microscopic examination of skin biopsy as a cost-effective tool in the diagnosis of lysosomal storage diseases","volume":"11","author":"Prasad","year":"1996","journal-title":"J. Child Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s004010050661","article-title":"Accumulation of mitochondrial ATP synthase subunit c in muscle in a patient with neuronal ceroid lipofuscinosis (late infantile form)","volume":"93","author":"Umehara","year":"1997","journal-title":"Acta. Neuropathol. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0002-9440(10)61253-9","article-title":"Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease)","volume":"167","author":"Koike","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1750-3639.2004.tb00502.x","article-title":"Selectivity and types of cell death in the neuronal ceroid lipofuscinoses","volume":"14","author":"Mitchison","year":"2004","journal-title":"Brain Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","article-title":"New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses","volume":"79","author":"Williams","year":"2012","journal-title":"Neurology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-018-0300-6","article-title":"Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses","volume":"14","author":"Mukherjee","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.bbadis.2015.04.027","article-title":"Cell biology of the NCL proteins: What they do and don\u2019t do","volume":"1852","author":"Kovacs","year":"2015","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1073\/pnas.080508097","article-title":"The crystal structure of palmitoyl protein thioesterase 1 and the molecular basis of infantile neuronal ceroid lipofuscinosis","volume":"97","author":"Bellizzi","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","article-title":"Current and emerging treatment strategies for neuronal ceroid lipofuscinoses","volume":"33","author":"Kohlschutter","year":"2019","journal-title":"CNS Drugs"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.07.011","article-title":"Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis","volume":"119","author":"Fietz","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","article-title":"Therapeutic landscape for batten disease: Current treatments and future prospects","volume":"15","author":"Johnson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"102337","DOI":"10.1016\/j.isci.2021.102337","article-title":"The converging roles of Batten disease proteins in neurodegeneration and cancer","volume":"24","author":"Yap","year":"2021","journal-title":"iScience"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/MCB.06726-11","article-title":"The role of ceroid lipofuscinosis neuronal protein 5 (CLN5) in endosomal sorting","volume":"32","author":"Mamo","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cellsig.2017.11.001","article-title":"Cln5 is secreted and functions as a glycoside hydrolase in Dictyostelium","volume":"42","author":"Huber","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sun, G., Yao, F., Tian, Z., Ma, T., and Yang, Z. (2018). A first CLN6 variant case of late infantile neuronal ceroid lipofuscinosis caused by a homozygous mutation in a boy from China: A case report. BMC Med. Genet., 19.","DOI":"10.1186\/s12881-018-0690-x"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2018.07.013","article-title":"Discovery of a CLN7 model of Batten disease in non-human primates","volume":"119","author":"McBride","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41556-018-0240-y","article-title":"CLN8 safeguards lysosome biogenesis","volume":"20","author":"Luzio","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41556-018-0228-7","article-title":"CLN8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis","volume":"20","author":"Bajaj","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1212\/WNL.0000000000000981","article-title":"Cathepsin D deficiency causes juvenile-onset ataxia and distinctive muscle pathology","volume":"83","author":"Hersheson","year":"2014","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1086\/504159","article-title":"Cathepsin D deficiency is associated with a human neurodegenerative disorder","volume":"78","author":"Steinfeld","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajhg.2012.04.021","article-title":"Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage","volume":"90","author":"Smith","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15281","DOI":"10.1523\/JNEUROSCI.1629-14.2014","article-title":"ATP13A2\/PARK9 regulates secretion of exosomes and alpha-synuclein","volume":"34","author":"Tsunemi","year":"2014","journal-title":"J. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/00207454.2017.1403439","article-title":"Novel compound heterozygous mutations causing Kufs disease type B","volume":"128","author":"Wang","year":"2018","journal-title":"Int. J. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.25351","article-title":"KCTD7 deficiency defines a distinct neurodegenerative disorder with a conserved autophagy-lysosome defect","volume":"84","author":"Metz","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ajhg.2012.05.023","article-title":"A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system","volume":"91","author":"Staropoli","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1212\/01.WNL.0000041913.97883.8B","article-title":"An autoantibody to GAD65 in sera of patients with juvenile neuronal ceroid lipofuscinoses","volume":"59","author":"Chattopadhyay","year":"2002","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1056\/NEJMoa1712649","article-title":"Study of intraventricular cerliponase alfa for CLN2 disease","volume":"378","author":"Schulz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2017.12.434","article-title":"Gene therapy for mucopolysaccharidoses","volume":"123","author":"Sawamoto","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2004.03.005","article-title":"Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Griffey","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/hmg\/11.22.2709","article-title":"Cln3(Deltaex7\/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth","volume":"11","author":"Cotman","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9669","DOI":"10.1523\/JNEUROSCI.1635-16.2016","article-title":"Self-complementary AAV9 gene delivery partially corrects pathology associated with juvenile neuronal ceroid lipofuscinosis (CLN3)","volume":"36","author":"Bosch","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2013.11.011","article-title":"Inhibition of storage pathology in prenatal CLN5-deficient sheep neural cultures by lentiviral gene therapy","volume":"62","author":"Hughes","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.ymthe.2018.07.015","article-title":"Longitudinal in vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 batten disease","volume":"26","author":"Mitchell","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1021\/acs.jmedchem.5b01020","article-title":"Progress in the development of small molecule therapeutics for the treatment of neuronal ceroid lipofuscinoses (NCLs)","volume":"59","author":"Kinarivala","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/21678707.2019.1684258","article-title":"Advances in the Treatment of Neuronal Ceroid Lipofuscinosis","volume":"7","author":"Rosenberg","year":"2019","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/86554","article-title":"Lysosomal ceroid depletion by drugs: Therapeutic implications for a hereditary neurodegenerative disease of childhood","volume":"7","author":"Zhang","year":"2001","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-973661","article-title":"Palmitoyl-protein thioesterase and the molecular pathogenesis of infantile neuronal ceroid lipofuscinosis","volume":"28","author":"Hofmann","year":"1997","journal-title":"Neuropediatrics"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10545-011-9446-x","article-title":"Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis","volume":"35","author":"Roberts","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/8904_2013_226","article-title":"Substrate reduction therapy in four patients with milder CLN1 mutations and juvenile-onset batten disease using cysteamine bitartrate","volume":"11","author":"Gavin","year":"2013","journal-title":"JIMD Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1474-4422(14)70142-5","article-title":"Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: A pilot study","volume":"13","author":"Levin","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.24815","article-title":"Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3)","volume":"80","author":"Aldrich","year":"2016","journal-title":"Ann. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/j.ymthe.2017.04.021","article-title":"Fingolimod and teriflunomide attenuate neurodegeneration in mouse models of neuronal ceroid lipofuscinosis","volume":"25","author":"Groh","year":"2017","journal-title":"Mol. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jneuroim.2010.08.024","article-title":"Immunosuppression alters disease severity in juvenile Batten disease mice","volume":"230","author":"Seehafer","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/8904_2018_113","article-title":"Short-term administration of mycophenolate is well-tolerated in CLN3 disease (juvenile neuronal ceroid lipofuscinosis)","volume":"43","author":"Augustine","year":"2019","journal-title":"JIMD Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4161\/auto.19653","article-title":"MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB","volume":"8","author":"Martina","year":"2012","journal-title":"Autophagy"},{"key":"ref_56","first-page":"ra42","article-title":"The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis","volume":"5","author":"Petit","year":"2012","journal-title":"Sci. Signal."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"14338","DOI":"10.1038\/ncomms14338","article-title":"mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases","volume":"8","author":"Palmieri","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10734","DOI":"10.1039\/C5OB01526J","article-title":"Synthetic deoxynojirimycin derivatives bearing a thiolated, fluorinated or unsaturated N-alkyl chain: Identification of potent alpha-glucosidase and trehalase inhibitors as well as F508del-CFTR correctors","volume":"13","author":"Cendret","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10143","article-title":"Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons","volume":"51","author":"Dhar","year":"2002","journal-title":"Ann. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/acn3.625","article-title":"Flupirtine derivatives as potential treatment for the neuronal ceroid lipofuscinoses","volume":"5","author":"Makoukji","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1021\/acs.jmedchem.7b01199","article-title":"Discovery of aromatic carbamates that confer neuroprotective activity by enhancing autophagy and inducing the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2)","volume":"60","author":"Kinarivala","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/acsptsci.0c00077","article-title":"An iPSC-derived neuron model of CLN3 disease facilitates small molecule phenotypic screening","volume":"3","author":"Kinarivala","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Maalouf, K., Makoukji, J., Saab, S., Makhoul, N.J., Carmona, A.V., Kinarivala, N., Ghanem, N., Trippier, P.C., and Boustany, R.M. (2020). Exogenous flupirtine as potential treatment for CLN3 disease. Cells, 9.","DOI":"10.3390\/cells9081872"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.bbadis.2013.01.009","article-title":"Use of model organisms for the study of neuronal ceroid lipofuscinosis","volume":"1832","author":"Bond","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.nbd.2017.08.017","article-title":"Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions","volume":"108","author":"Katz","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/j.bbadis.2015.06.014","article-title":"The relevance of the storage of subunit c of ATP synthase in different forms and models of Batten disease (NCLs)","volume":"1852","author":"Palmer","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.nbd.2004.08.013","article-title":"Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons","volume":"18","author":"Jalanko","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.mt.6300049","article-title":"Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector","volume":"15","author":"Sondhi","year":"2007","journal-title":"Mol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/mt.2011.130","article-title":"Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Xu","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1242\/dmm.018804","article-title":"Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: The importance of genetic background and gender","volume":"8","author":"Kovacs","year":"2015","journal-title":"Dis. Models Mech."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/hum.2012.253","article-title":"Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene","volume":"25","author":"Sondhi","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1089\/hum.2016.049","article-title":"Using patient-specific induced pluripotent stem cells and wild-type mice to develop a gene augmentation-based strategy to treat CLN3-associated retinal degeneration","volume":"27","author":"Wiley","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm1595","article-title":"Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans?","volume":"13","author":"Courtine","year":"2007","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"van der Worp, H.B., Howells, D.W., Sena, E.S., Porritt, M.J., Rewell, S., O\u2019Collins, V., and Macleod, M.R. (2010). Can animal models of disease reliably inform human studies?. PLoS Med., 7.","DOI":"10.1371\/journal.pmed.1000245"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3171\/2013.3.PEDS12397","article-title":"Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis","volume":"11","author":"Selden","year":"2013","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"165559","DOI":"10.1016\/j.bbadis.2019.165559","article-title":"Cellular models of Batten disease","volume":"1866","author":"Minnis","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1534\/genetics.111.130765","article-title":"Yeast: An experimental organism for 21st Century biology","volume":"189","author":"Botstein","year":"2011","journal-title":"Genetics"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1126\/science.3287619","article-title":"Yeast: An experimental organism for modern biology","volume":"240","author":"Botstein","year":"1988","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"McLaren, M.D., Mathavarajah, S., and Huber, R.J. (2019). Recent insights into NCL protein function sing the model organism Dictyostelium discoideum. Cells, 8.","DOI":"10.3390\/cells8020115"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1096\/fj.08-110544","article-title":"Dictyostelium discoideum\u2014A promising expression system for the production of eukaryotic proteins","volume":"22","author":"Arya","year":"2008","journal-title":"FASEB J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.tins.2010.05.004","article-title":"\u2018Too much good news\u2019\u2014Are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer\u2019s disease?","volume":"33","author":"Zahs","year":"2010","journal-title":"Trends Neurosci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pneurobio.2008.01.001","article-title":"Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS","volume":"85","author":"Turner","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0009-8981(92)90028-O","article-title":"Abnormal lysosomal cathepsin activities in leukocytes and cultured skin fibroblasts in late infantile, but not in juvenile neuronal ceroid-lipofuscinosis (Batten disease)","volume":"208","author":"Bennett","year":"1992","journal-title":"Clin. Chim. Acta"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2009.02.099","article-title":"Spectral properties and mechanisms that underlie autofluorescent accumulations in Batten disease","volume":"382","author":"Seehafer","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.reth.2020.11.006","article-title":"iPSC for modeling neurodegenerative disorders","volume":"15","author":"Diaz","year":"2020","journal-title":"Regen. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41380-020-00999-7","article-title":"Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders","volume":"26","author":"Denis","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.3233\/JAD-190744","article-title":"Current and emerging pharmacological targets for the treatment of Alzheimer\u2019s disease","volume":"72","author":"Morsy","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnmol.2017.00050","article-title":"Modeling human neurological and neurodegenerative diseases: From induced pluripotent stem cells to neuronal differentiation and its applications in neurotrauma","volume":"10","author":"Bahmad","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrm3448","article-title":"Induced pluripotent stem cells: The new patient?","volume":"13","author":"Bellin","year":"2012","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: A decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.stem.2012.07.005","article-title":"Discovery of inhibitors of microglial neurotoxicity acting through multiple mechanisms using a stem-cell-based phenotypic assay","volume":"11","author":"Hoing","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/stem.2463","article-title":"Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells","volume":"35","author":"Li","year":"2017","journal-title":"Stem Cells"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41467-017-01125-y","article-title":"Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue","volume":"8","author":"Kawatou","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","article-title":"Induced Pluripotent Stem Cells Meet Genome Editing","volume":"18","author":"Hockemeyer","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-genet-112414-054926","article-title":"From genomics to gene therapy: Induced pluripotent stem cells meet genome editing","volume":"49","author":"Hotta","year":"2015","journal-title":"Annu. Rev. Genet."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.scr.2018.04.014","article-title":"Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line","volume":"29","author":"Zhang","year":"2018","journal-title":"Stem Cell Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/crispr.2017.0015","article-title":"CRISPR-Cas9-mediated correction of the 1.02 kb common deletion in CLN3 in induced pluripotent stem cells from patients with batten disease","volume":"1","author":"Burnight","year":"2018","journal-title":"CRISPR J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s40478-019-0871-7","article-title":"Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis","volume":"7","author":"Jarazo","year":"2019","journal-title":"Acta. Neuropathol. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0306-4522(00)00067-1","article-title":"Decreased levels of proteasome activity and proteasome expression in aging spinal cord","volume":"98","author":"Keller","year":"2000","journal-title":"Neuroscience"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13023-018-0798-2","article-title":"Neural stem cells for disease modeling and evaluation of therapeutics for infantile (CLN1\/PPT1) and late infantile (CLN2\/TPP1) neuronal ceroid lipofuscinoses","volume":"13","author":"Sima","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/hmg\/ddt596","article-title":"Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway","volume":"23","author":"Lojewski","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s42003-021-01682-5","article-title":"A human model of batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface","volume":"4","author":"Tang","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Uusi-Rauva, K., Blom, T., von Schantz-Fant, C., Blom, T., Jalanko, A., and Kyttala, A. (2017). Induced pluripotent stem cells derived from a CLN5 patient manifest phenotypic characteristics of neuronal ceroid lipofuscinoses. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18050955"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1074\/jbc.M114.621706","article-title":"Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function","volume":"290","author":"Chandrachud","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1039\/C4MT00032C","article-title":"Deregulation of biometal homeostasis: The missing link for neuronal ceroid lipofuscinoses?","volume":"6","author":"Grubman","year":"2014","journal-title":"Metallomics"},{"key":"ref_111","first-page":"7060","article-title":"Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3\u0394ex1\u22126 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease)","volume":"24","author":"Calvi","year":"2015","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/20\/6235\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:15:23Z","timestamp":1760166923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/20\/6235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":111,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["molecules26206235"],"URL":"https:\/\/doi.org\/10.3390\/molecules26206235","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}